Dr. Fekrazad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
28860 Plaza de Oro
Valencia, CA 91354Phone+1 708-997-4666Fax+1 661-951-0686
Education & Training
- University of New Mexico School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009
- University of Alabama Medical CenterResidency, Internal Medicine, 2004 - 2006
- Physicians Medical Center CarrawayResidency, Internal Medicine, 2003 - 2004
- Shiraz University of Medical SciencesClass of 1994
Certifications & Licensure
- CA State Medical License 2012 - 2025
- NM State Medical License 2005 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
- People's Caring Awards by Patients Living Through Cancer PTLC, 2012
- "Fellow of The Year" (Department of Internal Medicine) University of New Mexico, 2009
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsPhase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal CancerEmilio P. Araujo‐Mino, Yehuda Z. Patt, Cristina Murray‐Krezan, Joshua A. Hanson, Pranshu Bansal
The Oncologist. 2018-01-01 - 2 citationsHypertrophic Lichen Planus Mimicking Squamous Cell Carcinoma of SkinWaheed Murad, M. Houman Fekrazad
The Journal of the American Osteopathic Association. 2014-09-01 - 25 citationsA Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers.Julie E. Bauman, Monte Shaheen, Claire F. Verschraegen, Steven A. Belinsky, M. Houman Fekrazad
Translational Oncology. 2014-06-01
Journal Articles
- A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid CancersBauman J, Shaheen M, Verschraegen CF, Belinsky SA, Houman Fekrazad M, Lee FC, Rabinowitz I, Ravindranathan M, Jones DV Jr, Transl Oncol, 1/17/2014
- Spontaneous Regression of High Grade Primary Gastric Lymphoma in an Untreated Viral Hepatitis InfectionRojas-Hernandez CM, Coleman JF, Czuchlewski DR, Fekrazad MH, Leuk Lymphoma, 1/17/2014
- Hypertrophic Lichen Planus Mimicking Squamous Cell Carcinoma of SkinMurad W, Fekrazad MH, J Am Osteopath Assoc, 1/11/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Phase II Trial of Sorafenib and Capecitabine for Hepatocellular Carcinoma in Cirrhotic PatientsFekrazad MH, ASCO Annual Meeting, 1/1/2013
- Phase II Trial of Combination Oxaliplatin, Capecitabine, Celecoxib With Concurrent Radiation For Patients With Newly Diagnosed Resectable Rectal CancerFekrazad MH, ASCO GI, 1/1/2013
- Phase II Trial of Temsirolimus and Erlotinib in Patients With Recurrent/Metastatic, Platinum-Refractory Head and Neck Squamous Cell CarcinomaFekrazad MH, ASCO Annual Meeting, 1/1/2012
- Join now to see all
Lectures
- Transdermal Delivery of TKI's/Chemotherapy via Nanoparticle1/1/2014
- Hematology-Oncology EmergenciesUniversity of New Mexico - 1/1/2011
- EBV-Associated Follicular Dendritic Cell Tumor of The Spleen1/1/2007
Other
- Diagnosis, Prevention and Treatment of Rejection in Cardiac Transplantation, ThesisFekrazad MH, Sanjarian A
Shiraz University School of Medicine - 1/1/1993 - Effects of IV Metronidazole in Treatment of 31 Patients with PseudomembraneousFekrazad MH, Shiraz University School of Medicine Press
1/1/1993 - Effects of Hydralazine on 23 Preeclamptic PatientsFekrazad MH, Shiraz University School of Medicine Press
1/1/1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: